Dividend22 May 2026, 02:05 pm
SMS Pharma Declares ₹0.40 Dividend for FY26
AI Summary
SMS Pharmaceuticals Ltd. announced a final dividend of ₹0.40 per equity share (40%) for the financial year 2025-26, subject to member approval at the AGM. The board also approved the audited financial results for the fourth quarter and year ended March 31, 2026, and shifting of the registered office. Additionally, M/s. Annapragada & Co. was appointed as Cost Auditors and M/s. Adusumilli & Associates re-appointed as Internal Auditors for FY 2026-27.
Key Highlights
- Final dividend of ₹0.40 per share (40%) declared for FY26, pending AGM approval.
- Audited financial results for Q4 and FY26 approved with an 'Unmodified Opinion'.
- Registered office shifting approved within Hyderabad local limits effective May 25, 2026.
- M/s. Annapragada & Co. appointed as Cost Auditors for FY27.
- M/s. Adusumilli & Associates re-appointed as Internal Auditors for FY27.
Price Impact
More from SMSPHARMA